The effect of etiopathogenetic therapy of COVID-19 on the severity of the disease: results of a multicenter double-blind placebo-controlled randomized trial

The effect of etiopathogenetic therapy of COVID-19 on the severity of the disease: results of a multicenter double-blind placebo-controlled randomized trial

Aim. The search for etiopathogenetic agents to prevent the development of severe and extremely severe COVID-19 remains relevant. A placebo-controlled randomized clinical trial was conducted to evaluate the efficacy and safety of the antibody-based biological drug (Raphamin). Materials and methods. 7...

Full description

Bibliographic Details
Main Authors: Vladimir V. Nikiforov, Vladimir A. Petrov, Anatoly A. Stremoukhov, Marina G. Avdeeva, Yury G. Shvarts, Irina E. Kravchenko, Irina V. Nikolaeva, Svetlana E. Ushakova, Oksana N. Belousova, Natal'ia A. Eremina, Svetlana V. Teplykh, Ekaterina V. Mel'nikova, Natal'ia E. Kostinа
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2023-12-01
Series:Терапевтический архив
Subjects:
covid-19
reducing severe covid-19
raphamin
etiopathogenetic therapy covid-19
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/623522/139238

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/623522/139238

Similar Items